NR3C2 and neoplasm: There was a concomitant decrease in F4/80+ macrophages (P < 0.005) but there were no differences in the expression of mannose receptor (MR) or MHC class II (MHCII) on myeloid cells (Supplementary Fig. S1A) suggesting there were no major changes in the phenotype of tumor-associated macrophages (TAM).